Results 361 to 370 of about 1,283,588 (394)

Peripheral Vascular Disease [PDF]

New England Journal of Medicine, 1943
Carl K. Friedland, Robert W. Wilkins
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly  

Chemotherapy‐induced peripheral neurotoxicity: A critical analysis

Ca-A Cancer Journal for Clinicians, 2013
Susanna B Park, David Goldstein, Michael L Friedlander   +2 more
exaly  

Vascular endothelial growth factor: a neurovascular target in neurological diseases

Nature Reviews Neurology, 2016
Christian Lange, E. Storkebaum, C. R. Almodóvar, M. Dewerchin, P. Carmeliet   +4 more
semanticscholar   +1 more source

Vascular Access in Oncology Patients

Ca-A Cancer Journal for Clinicians, 2008
Maurizio A Gallieni, Mauro Pittiruti, Roberto Biffi   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment

Ca-A Cancer Journal for Clinicians, 2017
Heather Greenlee, Melissa J Dupont-Reyes, Lynda G Balneaves   +2 more
exaly  

Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

Ca-A Cancer Journal for Clinicians, 2012
Anne Covey
exaly  

DRUGS AND PERIPHERAL VASCULAR DISEASE*

Australasian Journal of Dermatology, 1978
openaire   +4 more sources

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Nature Medicine, 2020
Aaron J Wilk, Arjun Rustagi, Nancy Q Zhao   +2 more
exaly